Investigation of efficacy and safety of lanthanum carbonate in hyperphosphatemia patients treated with cinacalcet hydrochloride
Phase 4
- Conditions
- Hyperphosphatemia patients treated with cinacalcet hydrochloride for secondary hyperparathyroidism
- Registration Number
- JPRN-UMIN000002481
- Lead Sponsor
- Shigei medical research hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pts who meet the contraindiation criteria in package insert of lanthanum carbonate 2)Pregnant or possibly pregnant pts, pts on lactation 3)Inappropriate pts for this study according to the investigator's judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum phosphate level
- Secondary Outcome Measures
Name Time Method 1. Corrected serum calcium, serum calcium phosphorus product, intact PTH 2. Adverse events 3. Drug compliance